Daily walnut intake improves metabolic syndrome status and increases circulating adiponectin levels: randomized controlled crossover trial.
Hyo-Jeong HwangYanan LiuHyun-Sook KimHeeseung LeeYunsook LimHyunjin ParkPublished in: Nutrition research and practice (2019)
A dietary supplement of 45 g of walnuts for 16 weeks favorably changed MetS status by increasing the concentration of HDL-C and decreasing fasting glucose level. Furthermore, consuming walnuts on a daily basis changed HbA1c and circulating adiponectin levels among the subjects with MetS. This trial is registered at ClinicalTrials.gov as NCT03267901.
Keyphrases
- metabolic syndrome
- phase iii
- open label
- phase ii
- insulin resistance
- double blind
- placebo controlled
- clinical trial
- study protocol
- blood glucose
- physical activity
- uric acid
- cardiovascular risk factors
- adipose tissue
- type diabetes
- randomized controlled trial
- cardiovascular disease
- weight gain
- skeletal muscle
- weight loss